Profiling the Fluid Assisted Dissemination of Pre-malignant cells in Fallopian Tubes

分析输卵管癌前细胞的液体辅助传播

基本信息

批准号：
10718158
负责人：
Geeta Mehta
金额：
$ 61.89万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-07-07 至 2028-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10718158
关键词：
3-Dimensional Abdominal Cavity Acceleration Affect Anatomy Animal Model BRCA1 gene Bioinformatics Biological Assay Biology Biophysical Process Bioreactors CDK4 gene Carcinoma Cell Culture Techniques Cell Death Cell Line Cells Collagen Complement Custom Cytoskeleton DNA Sequence Alteration Data Detection Development Disease Disease Progression Early Diagnosis Environment Epithelial Cells Epithelium Exposure to F-Actin Genes Genetic Genetic Variation Goals Greater sac of peritoneum Growth Harvest Human Immune Immune system Immunocompetent Immunocompromised Host Immunodeficient Mouse Immunologic Deficiency Syndromes Immunotherapy In Vitro Intraperitoneal Injections Invaded Lesion Link Liquid substance Location Malignant neoplasm of ovary Mammalian Oviducts Mechanics Microfluidic Microchips Microfluidics Modeling Molecular Molecular Profiling Movement Mus Mutate Mutation Neoplasm Metastasis Omentum Organ Ovarian Ovary Pathway interactions Patient-Focused Outcomes Patients Perfusion Peritoneal Peritoneum Pharmaceutical Preparations Play Polysaccharides Premalignant Cell Prevention Proliferating Proteomics Publishing RB1 gene Randomized Recurrent disease Regulation Research Role Scaffolding Protein Screening for Ovarian Cancer Secretory Cell Sepharose Serous Signal Pathway Signal Transduction Site Stage at Diagnosis Structure Surface Survival Rate TP53 gene Testing Tube Tumor Burden Validation Woman Work cancer cell cancer diagnosis cancer initiation cancer therapy cell growth clinical diagnosis clinical translation design and construction differential expression driver mutation early detection biomarkers effective therapy fluid flow gain of function genetic signature implantation improved in vivo in vivo Model intraperitoneal loss of function malignant breast neoplasm mechanical signal mechanical stimulus mechanotransduction migration mortality mouse model neoplastic cell novel screening shear stress sobriety statistics stem stemness subcutaneous trait transcriptome sequencing tumor tumor initiation tumor progression viscoelasticity

3-Dimensional Abdominal Cavity Acceleration Affect Anatomy Animal Model BRCA1 gene Bioinformatics Biological Assay Biology Biophysical Process Bioreactors CDK4 gene Carcinoma Cell Culture Techniques Cell Death Cell Line Cells Collagen Complement Custom Cytoskeleton DNA Sequence Alteration Data Detection Development Disease Disease Progression Early Diagnosis Environment Epithelial Cells Epithelium Exposure to F-Actin Genes Genetic Genetic Variation Goals Greater sac of peritoneum Growth Harvest Human Immune Immune system Immunocompetent Immunocompromised Host Immunodeficient Mouse Immunologic Deficiency Syndromes Immunotherapy In Vitro Intraperitoneal Injections Invaded Lesion Link Liquid substance Location Malignant neoplasm of ovary Mammalian Oviducts Mechanics Microfluidic Microchips Microfluidics Modeling Molecular Molecular Profiling Movement Mus Mutate Mutation Neoplasm Metastasis Omentum Organ Ovarian Ovary Pathway interactions Patient-Focused Outcomes Patients Perfusion Peritoneal Peritoneum Pharmaceutical Preparations Play Polysaccharides Premalignant Cell Prevention Proliferating Proteomics Publishing RB1 gene Randomized Recurrent disease Regulation Research Role Scaffolding Protein Screening for Ovarian Cancer Secretory Cell Sepharose Serous Signal Pathway Signal Transduction Site Stage at Diagnosis Structure Surface Survival Rate TP53 gene Testing Tube Tumor Burden Validation Woman Work cancer cell cancer diagnosis cancer initiation cancer therapy cell growth clinical diagnosis clinical translation design and construction differential expression driver mutation early detection biomarkers effective therapy fluid flow gain of function genetic signature implantation improved in vivo in vivo Model intraperitoneal loss of function malignant breast neoplasm mechanical signal mechanical stimulus mechanotransduction migration mortality mouse model neoplastic cell novel screening shear stress sobriety statistics stem stemness subcutaneous trait transcriptome sequencing tumor tumor initiation tumor progression viscoelasticity

展开

项目摘要

PROJECT SUMMARY The high mortality rate in ovarian cancers is explained in part, by late-stage clinical diagnosis where intraperitoneal tumor burden is already prevalent and widespread. Shedding and implantation of transformed secretory cells, originating from the fallopian tube, is considered one of the main initiators of ovarian cancer. During the early stages of this disease, secretory fallopian tube cells gain mutations that support migration (against the direction of fluid flow) to the ends of the fallopian tubes (fimbriae). At the fimbriae, the mutated fallopian tube cells form small early precursor lesions. Both the ovaries and fallopian tubes are suspended within the abdominal cavity, where the environment further exposes early precursor tumor cells to dynamic shear stresses. We therefore hypothesize that the fluidic shear stress stimulates the early precursor lesions in the fallopian tubes and modulates their dissemination to the ovary and peritoneal organs. In order to test this hypothesis, we will utilize microfluidic devices and bioreactors to circulate cell growth medium around transformed human and mouse fallopian tube cell lines that are supported on an agarose-collagen, polysaccharide-protein scaffold. Human immortalized fallopian tube cells with varying degrees of genetic mutation will be probed for changes in cell replication, migration, invasion, cell death, and genetic variation after stimulation of shear stress. Our preliminary data suggests a robust increase in the expression of GPRC5A in fallopian tube secretory epithelial cells (FTSEC) under shear stress stimulation. Therefore, we will validate this discovery in FTSEC cell lines with driver mutations and patient-derived cells, and investigate the GPRC5A molecular pathway and its components that are activated in FTSEC under shear stress stimulation, by utilizing gain-of-function and loss-of-function assays. Shear stressed and static control mutated fallopian tube cells will be tested for stemness and the capacity to initiate tumors in immunodeficient mice. Stimulated transformed fallopian tube cells will also be injected into immunocompromised mice to investigate the cell’s ability to colonize and form tumors. These studies will also be performed in mice with intact immune systems in order to assess whether immune cells impact growth and dissemination. Given that no published studies have yet identified the role of shear stresses in dissemination of early precursor lesions in ovarian cancers, the proposed work can potentially have much broader impact. For example, with our dynamic microfluidic and 3D bioreactor models, mechanotransduction and immunotherapy drugs can be screened for development of effective cancer therapies. The components of the shear stress-induced mechanotransduction that are identified in our proposed work, could also be utilized in early detection of ovarian cancers. As a result, the important role of shear stresses in the fluidic niches of ovarian cancers will be established. Lastly, our study on the mechanical regulation of transformed epithelial cells will be highly relevant to fundamental biology and clinical translational alike.

项目摘要卵巢癌的高死亡率部分通过后期临床诊断来解释腹膜内肿瘤伯恩已经普遍存在且宽度。转换和植入转化源自输卵管的秘书细胞被认为是卵巢癌的主要启动者之一。在这种疾病的早期阶段，秘书输卵管细胞获得了支持迁移的突变（靠在流体流动的方向上）到输卵管（fimbriae）的末端。在fimbriae，突变输卵管细胞形成小早期前体病变。卵巢和输卵管都被悬挂在腹腔，环境进一步将早期前体肿瘤细胞暴露于动态剪切压力。因此，我们假设流体剪切应力刺激了早期的前体病变输卵管并调节其传播到卵巢和腹膜器官。为了检验该假设，我们将利用微流体设备和生物反应器来循环细胞生长培养基围绕在琼脂糖 - 胶原上支撑的转化的人和小鼠输卵管细胞系，多糖蛋白脚手架。人生永生的输卵管细胞，具有不同程度的普通元将探测突变的细胞复制，迁移，侵袭，细胞死亡和遗传变异的变化刺激剪切应力。我们的初步数据表明，GPRC5a在在剪切应力刺激下，输卵管分泌上皮细胞（FTSEC）。因此，我们将验证这个在具有驱动器突变和患者衍生细胞的FTSEC细胞系中发现，并研究GPRC5A 通过使用，在剪切应力刺激下在FTSEC中激活的分子途径及其成分，通过使用功能障碍和功能丧失测定法。剪切应力和静态对照突变的输卵管细胞将在免疫缺陷小鼠中启动肿瘤的肿瘤的能力进行测试。刺激转换输卵管细胞也将被注入免疫功能低下的小鼠，以研究细胞定居的能力并形成肿瘤。这些研究也将在具有完整免疫系统的小鼠中进行，以评估免疫细胞是否影响生长和传播。鉴于尚无公开研究确定剪切应力在卵巢癌中早期前体病变传播中的作用，拟议的工作可以可能产生更大的影响。例如，使用我们的动态微流体和3D生物反应器模型，可以筛选机械转导和免疫疗法药物以开发有效的癌症疗法。剪切应力诱导的机械转导的成分是在我们提出的工作中确定的也可以在早期检测卵巢癌中使用。结果，剪切应力在将建立卵巢癌的液体壁ni。最后，我们对机械调节的研究转化的上皮细胞将与基本生物学和临床翻译高度相关。